NYXH logo

NYXH
Nyxoah SA

372
Mkt Cap
$142.34M
Volume
66,268.00
52W High
$8.64
52W Low
$2.76
PE Ratio
-1.22
NYXH Fundamentals
Price
$3.26
Prev Close
$3.20
Open
$3.22
50D MA
$3.23
Beta
0.71
Avg. Volume
35,377.37
EPS (Annual)
-$2.67
P/B
2.43
$175.87
Loading...
Loading...
News
all
press releases
Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of +57.17% and -6.68%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
More News
News Placeholder
Nyxoah (NYXH) Projected to Post Earnings on Tuesday
Nyxoah (NASDAQ:NYXH) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-nyxoah-sa-stock...
MarketBeat·4d ago
News Placeholder
Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Nyxoah (NYXH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·4d ago
News Placeholder
Tenet Healthcare (THC) Q1 Earnings Top Estimates
Tenet (THC) delivered earnings and revenue surprises of +14.39% and -0.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Nyxoah (NASDAQ:NYXH) Price Target Lowered to $8.00 at Stifel Nicolaus
Stifel Nicolaus reduced their price target on shares of Nyxoah from $10.00 to $8.00 and set a "buy" rating on the stock in a research report on Friday...
MarketBeat·29d ago
News Placeholder
Nyxoah SA (NASDAQ:NYXH) Receives Consensus Rating of "Moderate Buy" from Brokerages
Nyxoah SA (NASDAQ:NYXH - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five ratings firms that are presently covering the firm, MarketBeat.com reports. One analyst has...
MarketBeat·1mo ago
News Placeholder
Nyxoah's (NYXH) Overweight Rating Reaffirmed at Cantor Fitzgerald
Cantor Fitzgerald reiterated an "overweight" rating and set a $11.00 price objective on shares of Nyxoah in a research report on Monday...
MarketBeat·2mo ago
News Placeholder
Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026
Nyxoah (NASDAQ:NYXH) used its presentation at Oppenheimer's MedTech and Services Conference 2026 to outline the company's early U.S. launch progress for its Genio system, a neuromodulation therapy...
MarketBeat·2mo ago
News Placeholder
Stifel Nicolaus Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price
Stifel Nicolaus lowered their price target on Nyxoah from $11.00 to $10.00 and set a "buy" rating for the company in a report on Friday...
MarketBeat·2mo ago
News Placeholder
Nyxoah (NASDAQ:NYXH) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS
Nyxoah (NASDAQ:NYXH - Get Free Report) posted its earnings results on Thursday. The company reported ($0.69) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.65) by ($0.04). The company had revenue of $6.62 million for the quarter, compared to analyst estimates...
MarketBeat·2mo ago
<
1
2
...
>

Latest NYXH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.